Lexeo Therapeutics, Inc. · NASDAQ:LXEO

Orbimed Advisors LLC's stake in Lexeo Therapeutics, Inc. fell to 3.90% (Schedule 13G/A)

Event Sep 30, 2026 · Filed Nov 16, 2026

Orbimed Advisors LLC's stake in Lexeo Therapeutics, Inc. fell to 3.90%, 3,203,050 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).

Stake
3.90%
Shares
3,203,050
Intent
Passive
What changed
Fell below 5%
Filed together
2 holders

The filing in full

HolderStakeShares
OrbiMed Advisors LLC3.90%3,203,050
OrbiMed Capital LLC0%0

Source

Download original · View original at SEC

Related